BioNTech to start UK cancer vaccine trials using same mRNA tech found in its Covid-19 shots

Following the Covid-19 vaccine rollouts, BioNTech wants to use the same messenger-ribonucleic-acid technology (mRNA) tech in other therapies, including cancer vaccines. The treatments, tailor-made for an individual, provide immune systems with genetic code from a specific cancer so only the tumor can be targeted. An improvement over chemotherapy, which attacks...





from TechSpot https://ift.tt/gpVk4hb